Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)

Clinical trial NCT05224934 · RECRUITING

Trial details

NCT number: NCT05224934
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Soft Tissue Sarcoma Retroperitoneal Sarcoma Radiotherapy Side Effect Ultra-hypofractionated Radiotherapy Stereotactic Ablative Radiotherapy

Start date: 2022-01-01
Primary completion: 2027-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.